Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $418.8400 (0.35%) ($410.0000 - $420.4800) on Fri. Jan. 18, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.36% (three month average) | RSI | 87 | Latest Price | $418.8400(0.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.5% a day on average for past five trading days. | Weekly Trend | REGN advances 4.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(59%) XLV(48%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -1.18% in a week (0% probabilities). VXX(-11%) UUP(-11%) TLT(-6%) XHB(-3%) TIP(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.18% (StdDev 2.36%) | Hourly BBV | 0 () | Intraday Trend | -0.4% | | | |
|
5 Day Moving Average | $409.3(2.33%) | 10 Day Moving Average | $406.05(3.15%) | 20 Day Moving Average | $386.65(8.33%) | To recent high | 0% | To recent low | 24.7% | Market Cap | $44.409b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |